Tumour ischaemia by interferon-? resembles physiological blood vessel regression.
Authors:Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, Ivanov A, Szymborska A, Patone G, Kunz S, Sommermeyer D, Engels B, Leisegang M, Textor A, Fehling HJ, Fruttiger M, Lohoff M, Herrmann A, Yu H, Weichselbaum R, Uckert W, Hübner N, Gerhardt H, Beule D, Schreiber H, Blankenstein T
Journal:Nature
PubMed ID:28445461
'The relative contribution of the effector molecules produced by T cells to tumour rejection is unclear, but interferon-? (IFN?) is critical in most of the analysed models. Although IFN? can impede tumour growth by acting directly on cancer cells, it must also act on the tumour stroma for effective rejection ... More